Advanced cervical carcinoma associated with pregnancy

Area of Science:

• Gynecology
• Oncology
• Obstetrics

Background:

• Cervical cancer during pregnancy is rare but presents unique management challenges.
• Advanced cervical carcinoma (FIGO stages IB-IV) diagnosed in pregnant or postpartum women requires careful consideration.

Purpose of the Study:

• To compare outcomes of advanced cervical cancer in pregnant/postpartum patients versus non-pregnant controls.
• To analyze the impact of diagnosis timing (antenatal vs. postpartum) and delivery mode on survival.

Main Methods:

• Retrospective study of 62 patients with invasive cervical carcinoma diagnosed during pregnancy or within one year postpartum.
• Comparison with a control group of advanced cervical cancer patients without pregnancy association.
• Analysis of treatment modalities, mode of delivery, and survival rates.

Main Results:

• 54.8% of pregnant/postpartum patients had advanced disease (stages IIB-IV), a higher proportion than in comparable studies.
• Pregnant patients were significantly younger than controls.
• Overall treatment and survival rates were similar between pregnant/postpartum and control groups.
• Mode of delivery (vaginal vs. abdominal) did not affect survival.
• A trend towards worse outcomes was observed for antenatal diagnoses compared to postpartum diagnoses, though not statistically significant.

Conclusions:

• Advanced cervical carcinoma associated with pregnancy has similar survival outcomes to non-pregnant patients despite a higher proportion presenting with advanced disease.
• Age and delivery mode do not appear to be significant prognostic factors in this cohort.
• Antenatal diagnosis may be associated with a less favorable outcome, warranting further investigation.